Liew, FelicityEfstathiou, ClaudiaFontanella, SaraRichardson, MatthewSaunders, RuthSwieboda, DawidSidhu, Jasmin K.Ascough, StephanieMoore, Shona C.Mohamed, NouraNunag, JoseKing, ClaraLeavy, Olivia C.Elneima, OmerMcAuley, Hamish J.C.Shikotra, AartiSingapuri, AmishaSereno, MarcoHarris, Victoria C.Houchen-Wolloff, LinzyGreening, Neil J.Lone, Nazir I.Thorpe, MatthewThompson, A. A.RogerRowland-Jones, Sarah L.Docherty, Annemarie B.Chalmers, James D.Ho, Ling PeiHorsley, AlexanderRaman, BettyPoinasamy, KrisnahMarks, MichaelKon, Onn MinHoward, Luke S.Wootton, Daniel G.Quint, Jennifer K.de Silva, Thushan I.Ho, AntoniaChiu, ChristopherHarrison, Ewen M.Greenhalf, WilliamBaillie, J. KennethSemple, Malcolm G.Turtle, LanceEvans, Rachael A.Wain, Louise V.Brightling, ChristopherThwaites, Ryan S.Openshaw, Peter J. M.PHOSP-COVID collaborative groupISARIC investigators2024-08-302024-08-302024-04-08Liew, F, Efstathiou, C, Fontanella, S, Richardson, M, Saunders, R, Swieboda, D, Sidhu, J K, Ascough, S, Moore, S C, Mohamed, N, Nunag, J, King, C, Leavy, O C, Elneima, O, McAuley, H J C, Shikotra, A, Singapuri, A, Sereno, M, Harris, V C, Houchen-Wolloff, L, Greening, N J, Lone, N I, Thorpe, M, Thompson, A A R, Rowland-Jones, S L, Docherty, A B, Chalmers, J D, Ho, L P, Horsley, A, Raman, B, Poinasamy, K, Marks, M, Kon, O M, Howard, L S, Wootton, D G, Quint, J K, de Silva, T I, Ho, A, Chiu, C, Harrison, E M, Greenhalf, W, Baillie, J K, Semple, M G, Turtle, L, Evans, R A, Wain, L V, Brightling, C, Thwaites, R S, Openshaw, P J M, PHOSP-COVID collaborative group & ISARIC investigators 2024, 'Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease', Nature Immunology, vol. 25, no. 4, pp. 607-621. https://doi.org/10.1038/s41590-024-01778-01529-2908ORCID: /0000-0003-1336-7744/work/166663554https://hdl.handle.net/2164/24138We thank all the participants and their families. We thank the many research administrators, health-care and social-care professionals who contributed to setting up and delivering the PHOSP-COVID study at all of the 65 NHS trusts/health boards and 25 research institutions across the United Kingdom, as well as those who contributed to setting up and delivering the ISARIC4C study at 305 NHS trusts/health boards. We also thank all the supporting staff at the NIHR Clinical Research Network, Health Research Authority, Research Ethics Committee, Department of Health and Social Care, Public Health Scotland and Public Health England. We thank K. Holmes at the NIHR Office for Clinical Research Infrastructure for her support in coordinating the charities group. The PHOSP-COVID industry framework was formed to provide advice and support in commercial discussions, and we thank the Association of the British Pharmaceutical Industry as well the NIHR Office for Clinical Research Infrastructure for coordinating this. We are very grateful to all the charities that have provided insight to the study: Action Pulmonary Fibrosis, Alzheimer\u2019s Research UK, Asthma and Lung UK, British Heart Foundation, Diabetes UK, Cystic Fibrosis Trust, Kidney Research UK, MQ Mental Health, Muscular Dystrophy UK, Stroke Association Blood Cancer UK, McPin Foundations and Versus Arthritis. We thank the NIHR Leicester Biomedical Research Centre patient and public involvement group and Long Covid Support. We also thank G. Khandaker and D. C. Newcomb who provided valuable feedback on this work. Extended Data Fig. was created using Biorender.1515169287engR Medicine (General)Immunology and AllergyImmunologySupplementary DataDASSupplementary InformationR1Journal item10.1038/s41590-024-01778-0http://www.scopus.com/inward/record.url?scp=85190085946&partnerID=8YFLogxK254